Lloyd School of Pharmacy felicitates Atul Nasa
He has been nominated as the President of the 65th Indian Pharmacy Congress
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Eli Lilly appoints Edgard Olaizola as MD India operations
Has over 13 years of diversified experience in Lilly
Aditya Birla Memorial Hospital, Pune to organise national conference on pharmacy
More than 300 speakers and delegates are going to participate
A Radio ‘Logical’ Solution
Nuclear medicine is being used more oftern to treat life threatening diseases. Sachin Jagdale analyses the latest happenings in…
Scientists from University of Strathclyde invents technology to treat major illnesses
‘Shapeshifting’ computer programme will open up drug discovery for tricky disease targets
Almac Discovery and Queens launch £13 million cancer drug discovery partnership
Involving up to 60 ovarian cancer patients, the drug being trialled has been created as a result of an earlier collaboration…
Heart disease patients benefit from polypill in major international trial
The polypill group also had lower blood pressure and cholesterol measurements
Ranbaxy receives Paragraph IV certification notice from Watson Labs
Application filed to US FDA for generic version of Absorica
Clariant Chemicals (India) board proposes relocation of Masterbatches plant
The Board of Directors of Clariant Chemicals (India) have approved the proposal to relocate the Masterbatches plant of the company…
Better than Statins
Even as the statin market faces generic erosion, pharma companies are trying to figure out novel drugs and fixed dose combinations…
’Patient adherence team spending more than doubled from 2009 to 2011’
M Neelam Kachhap speakes to Manish Gupta, Chief Executive Officer, Indegene Lifesystems Bangalore, to know more about the rising…
UKTI signs MoU with ABLE
Will aim at combining UK's heritage and leadership in the area of healthcare and life sciences and India's emerging and thriving…
Competition intensifies as pharma companies race to launch type II diabetes drugs
New Frost & Sullivan report analysis which products will eventually succeed and why, in the race against time
Avesthagen signs license agreement with AvestaDHATM
Through the non-exclusive agreement, Avesthagen stands to earn $30 million over the next decade
Novo Nordisk launches basal insulin for adult patients with type I and type II diabetes
To be available in India soon
US FDA accepts Boehringer Ingelheims supplemental new drug application
To be used for use of dabigatran etexilate mesylate in deep vein thrombosis and pulmonary embolism
Bilcare starts field validation studies of its nonClonableID technology
Developed in collaboration with CSIR, the system aims to secure the pharma supply chain as well as improve patient compliance